Advancements in CT and MRI for Cancer Therapy-Related Cardiotoxicity
10.3969/j.issn.1005-5185.2025.02.002
- VernacularTitle:肿瘤治疗相关心脏毒性CT和MRI进展
- Author:
Jiuquan ZHANG
1
;
Hesong SHEN
1
Author Information
1. 重庆大学附属肿瘤医院影像科,重庆 400030
- Publication Type:Journal Article
- Keywords:
Neoplasms;
Cardiotoxicity;
Tomography,X-ray computed;
Magnetic resonance imaging;
Therapy;
Review
- From:
Chinese Journal of Medical Imaging
2025;33(2):116-120
- CountryChina
- Language:Chinese
-
Abstract:
Cancer therapy-related cardiotoxicity is the leading cause of non-cancer death in cancer patients.Anthracycline-based chemotherapy,targeted therapy,radiotherapy and immune checkpoint inhibitors often cause cardiotoxicity,but their mechanisms are different.Consequently,the formulation of an effective risk stratification and longitudinal monitoring strategy is imperative for the early detection and timely management of cardiotoxicity,thereby enhancing patient prognosis.CT and MRI play an important role in baseline risk stratification and longitudinal monitoring of cancer therapy-related cardiotoxicity.This article provides a comprehensive review of recent advancements in the application of CT and MRI for the evaluation of cancer therapy-related cardiotoxicity.
